IRADIMED CORP
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Stockholders’ Equity
| | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · · · · Accumulated · · | |||||||||||||||||
| · · · · · · · Additional · · · · · Other · · | |||||||||||||||||
| · · Common Stock · · Paid-in · · Retained · · Comprehensive · · Stockholders’ | |||||||||||||||||
| · Shares · Amount · Capital · Earnings · (Loss) Income · Equity | |||||||||||||||||
| Balances, December 31, 2021 | 12,544,024 | $1,254 | $25,160,618 | $46,994,922 | $17,012 | $72,173,806 | |||||||||||
| Net income | — | | | — | | | — | | | 12,828,487 | | | — | | | 12,828,487 | |
| Dividends paid | — | | | — | | | — | | | (12,559,127) | | | — | | | (12,559,127) | |
| Other comprehensive loss | — | | | — | | | — | | | — | | | (17,012) | | | (17,012) | |
| Stock-based compensation | — | | | — | | | 1,394,106 | | | — | | | — | | | 1,394,106 | |
| Net share settlement of restricted stock units | 31,414 | | | 3 | | | (293,984) | | | — | | | — | | | (293,981) | |
| Exercise of stock options | 15,566 | | | 2 | | | 146,706 | | | — | | | — | | | 146,708 | |
| Balances, December 31, 2022 | 12,591,004 | $1,259 | $26,407,446 | $47,264,282 | $— | $73,672,987 | |||||||||||
| Net income | — | | | — | | | — | | | 17,192,776 | | | — | | | 17,192,776 | |
| Dividends paid or accrued | — | | | — | | | — | | | (21,198,904) | | | — | | | (21,198,904) | |
| Stock-based compensation expense | — | | | — | | | 2,186,909 | | | — | | | — | | | 2,186,909 | |
| Net share settlement of restricted stock units | 41,879 | | | 4 | | | (610,345) | | | — | | | — | | | (610,341) | |
| Net share settlement of performance based stock units | | 6,430 | | | — | | | — | | | — | | | — | | | — |
| Exercise of stock options | 21,000 | | | 2 | | | 176,735 | | | — | | | — | | | 176,737 | |
| Balances, December 31, 2023 | 12,660,313 | $1,265 | $28,160,745 | $43,258,154 | $— | $71,420,164 | |||||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.